Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-03-2021 | Herpes Virus | Case report

Immunosuppressants

Molluscum contagiosum, herpes simplex virus infections and eczema herpeticum: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Guly J, et al. Stopping immunomodulatory immunoglobulin therapy in an adult patient with atopic dermatitis on dupilumab. Clinical and Experimental Allergy 51: 170-171, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/cea.13812 [abstract] Guly J, et al. Stopping immunomodulatory immunoglobulin therapy in an adult patient with atopic dermatitis on dupilumab. Clinical and Experimental Allergy 51: 170-171, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/cea.13812 [abstract]
Metadata
Title
Immunosuppressants
Molluscum contagiosum, herpes simplex virus infections and eczema herpeticum: case report
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-92422-9

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Immune globulin

Case report

Prednisolone

Case report

Doxazosin

Case report

Rituximab